FDA Inspection 1099919 — Novartis Pharma AG
The FDA completed an inspection of Novartis Pharma AG on Jul 12, 2019 in Basel Town. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 12, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Basel Town (Switzerland)